| Year |
Citation |
Score |
| 2013 |
Israyelyan A, La Rosa C, Tsai W, Kaltcheva T, Srivastava T, Aquino L, Li J, Kim Y, Palmer J, Streja L, Senitzer D, Zaia JA, Rosenwald A, Forman SJ, Nakamura R, et al. Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma. 54: 2490-9. PMID 23480492 DOI: 10.3109/10428194.2013.783910 |
0.306 |
|
| 2012 |
Israyelyan A, Sandoval F, Baghian A, Kearney MT, Shannon EJ. Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice. Immunopharmacology and Immunotoxicology. 34: 408-12. PMID 21942927 DOI: 10.3109/08923973.2011.611519 |
0.464 |
|
| 2009 |
Israyelyan A, Shannon EJ, Baghian A, Kearney MT, Kousoulas KG. Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn. Cancer Chemotherapy and Pharmacology. 64: 1201-10. PMID 19308409 DOI: 10.1007/s00280-009-0987-8 |
0.676 |
|
| 2008 |
Israyelyan A, Chouljenko VN, Baghian A, David AT, Kearney MT, Kousoulas KG. Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice. Virology Journal. 5: 68. PMID 18518998 DOI: 10.1186/1743-422X-5-68 |
0.702 |
|
| 2007 |
Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells. Human Gene Therapy. 18: 457-73. PMID 17536976 DOI: 10.1089/Hum.2006.145 |
0.307 |
|
| Show low-probability matches. |